All In Biotech

Drug Trial Radar · NCT05844982

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

A Trial Evaluating Intravitreal Faricimab (6.0 mg) Injections or Fluocinolone Acetonide (0.19 mg Intravitreal Implants vs Observation for Prevention of Visual Acuity Loss Due to Radiation Retinopathy

Last checked: Nov 19, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 600 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

600

Planned (sponsor's estimate)

Start

Nov 21, 2023

Primary completion

Dec 26, 2029

Study completion Dec 26, 2029

Sponsor

Lead sponsor
Jaeb Center for Health ResearchAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Eye Institute (NEI); National Institutes of Health (NIH); Alimera Sciences; Genentech, Inc.
First posted
May 6, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This randomized controlled trial will evaluate the effect of intravitreal faricimab or fluocinolone acetonide (FAc) intravitreal implant compared with observation on long-term visual acuity following treatment of choroidal melanoma with iodine-125 plaque brachytherapy.

Conditions

  • Radiation Retinopathy
  • Visual Impairment

Interventions

  • FaricimabDrug

    6.0 mg intravitreal injection at randomization and every 3 months

  • fluocinolone acetonideDrug

    0.19 mg fluocinolone acetonide intravitreal implant (Iluvien) at randomization and at 24 months

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in visual acuity from baselineTime frame: from baseline at 3 years
  2. Loss of 15 or more letters of visual acuity from baselineTime frame: from baseline at 3 years

Locations

29 sites in 1 country. Site status is shown where the registry gives one.

  • Byers Eye Institute at Stanford University

    Palo Alto, California · Recruiting

  • Retina Consultants

    Manchester, Connecticut · Recruiting

  • Retina Associates of Florida, LLC

    Tampa, Florida · Recruiting

  • Emory Eye Center

    Atlanta, Georgia · Recruiting

  • Northwestern Memorial Group

    Chicago, Illinois · Recruiting

  • IL Eye and Ear Infirmary-University of Illinois at Chicago

    Chicago, Illinois · Recruiting

  • Midwest Eye Institute

    Indianapolis, Indiana · Recruiting

  • University of Iowa Department of Ophthalmology and Visual Sciences

    Iowa City, Iowa · Recruiting

  • University of Kentucky Advanced Eye Care

    Lexington, Kentucky · Recruiting

  • Massachusetts Eye and Ear

    Boston, Massachusetts · Recruiting

  • Foundation for Vision Research and Retina Specialists of Michigan, P.C.

    Grand Rapids, Michigan · Recruiting

  • Associated Retinal Consultants, P.C.

    Royal Oak, Michigan · Recruiting

  • Mayo Clinic

    Rochester, Minnesota · Recruiting

  • Washington University Ophthalmology

    St Louis, Missouri · Recruiting

  • Retina Research Institute, LLC

    St Louis, Missouri · Recruiting

  • Duke Eye Center

    Durham, North Carolina · Recruiting

  • The Cleveland Clinic Foundation DBA Cleveland Clinic Lerner College of Medicine

    Celveland, Ohio · Recruiting

  • Oregon Health & Science University

    Portland, Oregon · Recruiting

  • Retina-Vitreous Consultants, Inc.

    Monroeville, Pennsylvania · Recruiting

  • Wills Eye Hospital

    Philadelphia, Pennsylvania · Recruiting

  • Pittsburgh Clinical Trial Consortium

    Sewickley, Pennsylvania · Recruiting

  • Retina Consultants of Carolina, PA

    Greenville, South Carolina · Recruiting

  • Southeastern Retina Associates

    Hixson, Tennessee · Recruiting

  • Tennessee Retina, PC

    Nashville, Tennessee · Recruiting

  • Retina Consultants of Texas, PA

    Bellaire, Texas · Recruiting

  • UT Southwestern Medical Center

    Dallas, Texas · Recruiting

  • Eye Cancer Associates of Texas

    Houston, Texas · Recruiting

  • Texas Retina Associates

    Lubbock, Texas · Recruiting

  • The Board of Regents of the University of Wisconsin System

    Madison, Wisconsin · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.